Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at SGD 105.6B, ahead of Gilead Sciences (SGD 46.9B) and Biogen (SGD 14.4B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenSGD 105.6B
Median
SGD 906.7M
Combined market value
SGD 1.09T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSGD 105.6BSGD 313.5BSGD 579.56 1.85% down 34% up United States
2Gilead SciencesGILD · Health CareSGD 46.9BSGD 270.5BSGD 218.05 0.68% down 33% up United States
3BiogenBIIB · Health CareSGD 14.4BSGD 47.8BSGD 323.06 0.10% down 49% up United States
4ModernaMRNA · Health CareSGD 4.8BSGD 105.7BSGD 261.11 2.08% down 755% up United States
5BioNTechBNTX · Health CareSGD 4BSGD 27.1BSGD 109.20 0.20% down 16% down Germany
6QiagenQGEN · Health CareSGD 3.2BSGD 13.2BSGD 64.06 0.13% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareSGD 3.2BSGD 14.1BSGD 123.58 0.13% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareSGD 1.8BSGD 21.5BSGD 212.39 0.72% down 20% up United States
9argenxARGX · Health CareSGD 1.8BSGD 77.7BSGD 1,234.86 1.07% up 4% up Belgium
10ImmunityBioIBRX · Health CareSGD 1.3BSGD 8.4BSGD 7.93 1.76% down 193% up United States
11RepligenRGEN · Health CareSGD 1.1BSGD 14BSGD 219.57 5.00% up 5% up United States
12Revolution MedicinesRVMD · Health CareSGD 932.5MSGD 44.2BSGD 204.49 2.52% down 131% up United States
13ExelixisEXEL · Health CareSGD 880.8MSGD 21.6BSGD 88.40 0.09% up 63% up United States
14Bio-TechneTECH · Health CareSGD 617MSGD 14.7BSGD 93.78 0.14% up 26% up United States
15CRISPR TherapeuticsCRSP · Health CareSGD 442.8MSGD 5.2BSGD 53.36 3.06% up 21% down Switzerland
16VaxcytePCVX · Health CareSGD 409MSGD 12BSGD 75.75 1.09% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareSGD 371MSGD 5.9BSGD 36.61 0.35% down 88% up United States
18Kodiak SciencesKOD · Health CareSGD 250.3MSGD 8.1BSGD 124.30 0.41% down 396% up United States
19Twist BioscienceTWST · Health CareSGD 217.8MSGD 10BSGD 146.14 1.20% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareSGD 210.4MSGD 13.4BSGD 157.07 0.25% up 87% up United States
21Scholar Rock HoldingSRRK · Health CareSGD 204.7MSGD 7.4BSGD 60.70 4.43% up 14% up United States
22Krystal BiotechKRYS · Health CareSGD 147.3MSGD 11.6BSGD 390.80 1.52% up 46% up United States
23ImmunovantIMVT · Health CareSGD 134.6MSGD 8.9BSGD 42.98 0.38% up 43% up United States
24CG OncologyCGON · Health CareSGD 50.3MSGD 9BSGD 100.64 1.12% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2894 SGD).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (SGD 105.6B), Gilead Sciences (SGD 46.9B) and Biogen (SGD 14.4B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of SGD 1.09T as of 18 Nov 2026, 14:51 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.